Mineralys Therapeutics, Inc. (MLYS)
NASDAQ·Healthcare·Biotechnology
$26.10
-3.37%
Mkt Cap $1.91B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (7 analysts)
$46.00
Range $30.00 – $56.00
Implied Upside
+76.2%
Consensus $46.00 vs current $26.10
NASDAQ·Healthcare·Biotechnology
$26.10
-3.37%
Mkt Cap $1.91B
Buy
4
Hold
0
Sell
0
Price Target (7 analysts)
$46.00
Range $30.00 – $56.00
+76.2%
Consensus $46.00 vs current $26.10